Saint Luke's Hospital of Bethlehem v. Vivian

99 A.3d 534
CourtSuperior Court of Pennsylvania
DecidedAugust 18, 2014
StatusPublished
Cited by21 cases

This text of 99 A.3d 534 (Saint Luke's Hospital of Bethlehem v. Vivian) is published on Counsel Stack Legal Research, covering Superior Court of Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Saint Luke's Hospital of Bethlehem v. Vivian, 99 A.3d 534 (Pa. Ct. App. 2014).

Opinion

OPINION BY

ALLEN, J.:

St. Luke’s Hospital of Bethlehem, Pennsylvania d/b/a St. Luke’s Hospital and St. Luke’s Hospital & Health Network, (“Appellant”), appeals from the trial court’s order overruling Appellant’s claims of privilege, denying a protective order in favor of Appellant, and sanctioning Appellant pursuant to a motion by John R. Vivian, Jr. Esquire (“Attorney”) 1. We affirm.

Underlying the instant litigation are various wrongful death lawsuits initiated by the families of Appellant’s former patients, on the basis that one of Appellant’s former nurses, Charles Cullen (“Cullen”), caused the death of their loved ones. In a prior opinion involving one of these actions, we detailed the following factual background:

[Charles] Cullen began working as a nurse in the Coronary Care Unit (CCU) of [Appellant’s hospital] on June 5, 2000. On June 2, 2002, Hospital staff found various used and unused medications improperly disposed in a receptacle for used syringes, or a “sharps” bin, in the CCU. Through its nurse manager, [Appellant] commenced an investigation by, at first, monitoring the receptacle to see if the culprit would place any more unauthorized medicines in the bin. The next day, June 3, 2002, Nurse Gerald Kimble found the box full of used and unused containers of medications, including Vecuronium and nitroprusside.
Because the authorized use of these medications could not be substantiated, and with [Appellant’s] in-house counsel on administrative leave at the time, Risk Manager Jan Rader requested that outside counsel, Attorney Paul Laughlin, come to the Hospital and conduct an investigation on its behalf. Attorney Laughlin interviewed several employees, including Nurse Kimble, who informed him that Cullen had exhibited strange or quirky behavior. Attorney Laughlin did not interview Cullen at that time and left the hospital without identifying the culprit.
On June 4, 2002, at approximately 11:00 p.m., more used and unused medications were found in the sharps disposal bin in the CCU medication room. Risk Manager Rader reached Attorney Laughlin by telephone at approximately 2:00 a.m. on June 5, 2002, and expressed her concern that Cullen was to blame for the diversion of medications and that she wanted him removed from his job duties because he may have also been using those drugs to harm patients. Confronted by Attorney Laughlin, Cullen denied diverting medications but offered to resign; he was escorted from the Hospital by security. Later that day, on June 5, 2002, [Appellant] decided to accept his resignation and Cullen never returned to duty at [the hospital].
Attorney Laughlin recalls that he suggested patient charts be reviewed to ascertain whether the diverted Vecuroni-um had been improperly administered, thereby resulting in patient harm; however, the question of what precisely At[537]*537torney Laughlin learned during, and concluded from, his investigation is not clear. And in that respect, the deposition testimony of the various witnesses diverges considerably. Attorney Laugh-lin has indicated that particularized suspicion of Cullen harming patients was never brought to his attention. However, notes from his interviews in combination with the testimony of Nurse Patricia Medellin leave it within the purview of the finder of fact to draw a different inference.
Specifically, Nurse Medellin has stated she met with Attorney Laughlin on the night he confronted Cullen and that he had instructed her to call him if she “had any additional thoughts.” After learning that opened containers of Vecu-ronium had been found in the receptacles and that other nurses had concerns that patients may have been harmed, she telephoned Attorney Laughlin on or about June 7, 2002. She informed him that the unauthorized administration of Vecuronium would be consistent with unexplained slowing down of patient heart-rates, leading to “codes” when their hearts stopped. She also told Attorney Laughlin that no one in the CCU at that time should have been receiving Vecuronium.
In response to this, however, Attorney Laughlin informed Nurse Medellin that “the investigation was closed” and that he was “confident that Cullen was not in any way harming patients.” Nurse Medellin pressed Attorney Laughlin about how he could be so sure, especially when Attorney Laughlin had admitted to her that he had not compared the medications sent from the pharmacy versus those actually used on patients and had not compared the number of patient codes on day-versus night-shifts when Cullen was on duty. Attorney Laughlin allegedly responded that based on his experience as a prosecutor in Philadelphia for eight years, he was confident in his investigation and was “certain” that Cullen “was not hurting anyone.” He then informed her once again that the investigation was “closed and not open ... for further review.”
Nurse Medellin has also testified at deposition that she voiced her concerns to her supervisors, but that she was met with an equally inhospitable response. In particular, she stated that after Attorney Laughlin dismissed her concerns, she spoke to the Clinical Coordinator at [the hospital], Thelma Moyer, and the CCU Nurse Manager at [the hospital], Ellen Amedeo, both of whom dismissed her concerns and informed her that the investigation was closed. She also testified that after speaking with Attorney Laughlin, she compiled a list of the patients who died in the CCU and compared it to Cullen’s shifts, and determined that a disproportionate number of patients died while he was on duty. However, because of the lack of receptivity and “almost anger” expressed by Clinical Coordinator Moyer and CCU Nurse Manager Amedeo to her previous entreaties, Nurse Medellin did not present the list she compiled for fear of “repercussions.” Instead, she brought the matter to the attention of a police-officer friend of hers, who, in turn, arranged an appointment with the Lehigh County District Attorney.
Other nurses, including Judy Glessner and Darla Beers, have also testified that concern was present among the nursing staff that Cullen had harmed patients, but neither of those witnesses recalled expressing any particularized concerns to Laughlin. However, Assistant Pharmacy Director Susan Reed has testified that she recalled expressing to Laughlin that the nature of the empty medications [538]*538found, including Vecuronium, raised a concern about potential patient harm. And notes Attorney Laughlin apparently took during his conversation with Nurse Medellin contain abbreviated descriptions that could be understood as references to patients being harmed by Cullen and “cod[ing] fast.” Testimony from [Appellant’s] Vice President of Risk Management, Gary Guidetti, indicates, however, that Attorney Laughlin never apprised him of concerns about patient harm or otherwise passed those concerns onto upper management.
After he returned from leave in July 2002, the Hospital’s General Counsel, Seymour Traub, directed Attorney Laughlin to jprepare a report and ordered additional chart reviews to be performed by [Appellant’s] staff. General Counsel Traub testified that Attorney Laughlin never mentioned that any nurses had conveyed concerns about Cullen harming patients. Risk Manager Rader and Nursing Supervisor Roller were charged with reviewing charts of all of the patients who had died over the course of the weekend in which the diverted medications were found.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

King, C. v. Alpha Sigma Tau Sorority
Superior Court of Pennsylvania, 2025
McKeehan, D. & M. v. Milton Hershey Med Cntr
2024 Pa. Super. 290 (Superior Court of Pennsylvania, 2024)
Live Nation Entertainment v. Blumenfeld, E.
Superior Court of Pennsylvania, 2024
Vivian, J. v. St. Luke's Hospital
2024 Pa. Super. 118 (Superior Court of Pennsylvania, 2024)
Carlino East v. Brandywine Village Assoc.
2023 Pa. Super. 141 (Superior Court of Pennsylvania, 2023)
PENDERGRASS v. PENDERGRASS, II
E.D. Pennsylvania, 2020
Bollard & Assoc., Inc. v. Schmidt, G.
2019 Pa. Super. 345 (Superior Court of Pennsylvania, 2019)
In Re: Estate of Barkan, L., Appeal of: Barkan, E.
Superior Court of Pennsylvania, 2019
Corey, L. v. Wilkes-Barre Hospital
2019 Pa. Super. 288 (Superior Court of Pennsylvania, 2019)
Virnelson, T. v. Matthey, J.
Superior Court of Pennsylvania, 2019
Abramson, M. v. Novitsky, M.
Superior Court of Pennsylvania, 2017
Adoption of A.Z.F., Appeal of R.O.F.-F., father
Superior Court of Pennsylvania, 2017
de Botton, C. v. Kaplin, M.
Superior Court of Pennsylvania, 2017
Cabot Oil & Gas Corp. v. Scroggins, V.
Superior Court of Pennsylvania, 2016
Giovinazzo, J. v. Susquehanna Bank
Superior Court of Pennsylvania, 2016
Haas, M. v. Reinert, M.
Superior Court of Pennsylvania, 2016
Gen. Turf Grass, Inc. v. Synatek, LP
Superior Court of Pennsylvania, 2016
Haney, S. v. Range Resources
Superior Court of Pennsylvania, 2016
Custom Homes v. Young, J.
Superior Court of Pennsylvania, 2015

Cite This Page — Counsel Stack

Bluebook (online)
99 A.3d 534, Counsel Stack Legal Research, https://law.counselstack.com/opinion/saint-lukes-hospital-of-bethlehem-v-vivian-pasuperct-2014.